BlackRock Investment Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 38 filers reported holding CYTOSORBENTS CORP in Q1 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2016$21,000
-12.5%
3,7760.0%0.00%
Q3 2016$24,000
+41.2%
3,7760.0%0.00%
Q2 2016$17,000
+70.0%
3,776
+45.7%
0.00%
Q1 2016$10,000
-28.6%
2,5910.0%0.00%
Q4 2015$14,000
-6.7%
2,591
+7.4%
0.00%
Q3 2015$15,0000.0%2,4130.0%0.00%
Q2 2015$15,0002,4130.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 249,430$2,015,0001.24%
Manatuck Hill Partners, LLC 194,100$1,568,0000.81%
Skylands Capital, LLC 495,850$4,006,0000.66%
EAM Global Investors LLC 78,027$630,0000.34%
EAM Investors, LLC 107,531$869,0000.24%
Granahan Investment Management 278,170$2,248,0000.16%
Wealthcare Advisory Partners LLC 62,079$502,0000.10%
Avenir Corp 76,390$617,0000.08%
Crow Point Partners, LLC 48,576$380,0000.07%
Kalos Management, Inc. 14,700$120,0000.06%
View complete list of CYTOSORBENTS CORP shareholders